Pharmacological induction of peroxisomes in peroxisome biogenesis disorders

Annals of Neurology

Volumn 47, Issue 3, 2000, Pages 286-296

  Wei, Heming ^a   Kemp, Stephan ^a   McGuinness, Martina C ^a   Moser, Ann B ^a   Smith, Kirby D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; PEROXISOME PROLIFERATOR;

ADRENOLEUKODYSTROPHY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; PEROXISOME; PRIORITY JOURNAL; REFSUM DISEASE; ZELLWEGER SYNDROME;

CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FIBROBLASTS; HUMANS; INFANT; PEROXISOMAL DISORDERS; PEROXISOMES; PHENOTYPE; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034059821     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200003)47:3<286::AID-ANA3>3.0.CO;2-B     Document Type: Article

References (47)

1. De Duve C, Baudhuin P. Peroxisomes (microbodies and related particles). Physiol Rev 1966;46:323-357
2. Van den Bosch H, Schutgens RB, Wanders RJ, Tager JM. Biochemistry of peroxisomes. Annu Rev Biochem 1992;61:157-197
3. Gould SJ, Keller GA, Hosken N, et al. A conserved tripeptide sorts proteins to peroxisomes. J Cell Biol 1989;108:1657-1664
4. Swinkels BW, Gould SJ, Bodnar AG, et al. A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoA thiolase. Embo J 1991;10:3255-3262
5. Zhang JW, Lazarow PB. Peb1p (Pas7p) is an intraperoxisomal receptor for the NH2-terminal, type 2, peroxisomal targeting sequence of thiolase: Peb1p itself is targeted to peroxisomes by an NH2-terminal peptide. J Cell Biol 1996;132:325-334
6. Dyer JM, McNew JA, Goodman JM. The sorting sequence of the peroxisomal integral membrane protein PMP47 is contained within a short hydrophilic loop. J Cell Biol 1996;133: 269-280
7. Subramani S. Components involved in peroxisome import, biogenesis, proliferation, turnover, and movement. Physiol Rev 1998;78:171-188
8. Moser HW, Moser AB. Peroxisomal disorders: overview. Ann NY Acad Sci 1996;804:427-441
9. Lazarow PB, Moser HW. Disorders of peroxisome biogenesis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill, 1995:2287-2324
10. Ulrich J, Heitz P, Sigrist T, Baerlocher P. Adrenoleukodystrophy: preliminary report of a connatal case - light-and electron microscopical, immunohistological and biochemical findings. Acta Neuropathol (Berl) 1978;43:77-83
11. Poll-The BT, Saudubray JM, Ogier HA, et al. Infantile Refsum disease: an inherited peroxisomal disorder: comparison with Zellweger syndrome and neonatal adrenoleukodystrophy. Eur J Pediatr 1987;146:477-483
12. Moser AB, Rasmussen M, Naidu S, et al. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr 1995;127:13-22
13. Shimozawa N, Suzuki Y, Zhang Z, et al. Genetic basis of peroxisome-assembly mutants of humans, Chinese hamster ovary cells, and yeast: identification of a new complementation group of peroxisome-biogenesis disorders apparently lacking peroxisomal-membrane ghosts. Am J Hum Genet 1998;63: 1898-1903
14. Warren DS, Morrell JC, Moser HW, et al. Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders. Am J Hum Genet 1998;63: 347-359
15. Honsho MTS, Shimoza N, Suzuki Y, et al. Mutation in PEX 16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D. Am J Hum Genet 1998;63:1622-1630
16. South ST, Gould SJ. Peroxisome synthesis in the absence of preexisting peroxisomes. J Cell Biol 1999;144:255-266
17. Shimozawa N, Suzuki Y, Zhang Z, et al. Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders. Hum Mol Genet 1999;8:1077-1083
18. Matsuzono Y, Kinoshita N, Tamura S, et al. Human PEX 19: cDNA cloning by functional complementation, mutation analysis in a patient with Zellweger syndrome, and potential role in peroxisomal membrane assembly. Proc Natl Acad Sci USA 1999;96:2116-2121
19. Dodt G, Braverman N, Valle D, Gould SJ. From expressed sequence tags to peroxisome biogenesis disorder genes. Ann NY Acad Sci 1996;804:516-523
20. Reddy JK, Chu R. Peroxisome proliferator-induced pleiotropic responses: pursuit of a phenomenon. Ann NY Acad Sci 1996; 804:176-201
21. Kemp S, Wei HM, Lu JF, et al. Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy. Nat Med 1998;4:1261-1268
22. Braiterman LT, Zheng S, Watkins PA, et al. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins. Hum Mol Genet 1998;7:239-247
23. Maestri NE, Brusilow SW, Clissold DB, Bassett SS. Long-term treatment of girls with ornithine transcarbamylase deficiency. N Engl J Med 1996;335:855-859
24. Samid D, Hudgins WR, Shack S, et al. Phenylacetare and phenylbutyrate as novel, nontoxic differentiation inducers. Adv Exp Med Biol 1997;400A:501-505
25. Chang C, South S, Warren D, et al. Metabolic control of peroxisome abundance. J Cell Sci 1999;112:1579-1590
26. Santos MJ, Imanaka T, Shio H, Lazarow PB. Peroxisomal integral membrane proteins in control and Zellweger fibroblasts. J Biol Chem 1988;263:10502-10509
27. Santos MJ, Imanaka T, Shio H, et al. Peroxisomal membrane ghosts in Zellweger syndrome - aberrant organelle assembly. Science 1988;239:1536-1538
28. Santos MJ, Hoefler S, Moser AB, Lazarow PB. Peroxisome assembly mutations in humans: structural heterogeneity in Zellweger syndrome. J Cell Physiol 1992;151:103-112
29. Albertini M, Rehling P, Erdmann R, et al. Pex14p, a peroxisomal membrane protein binding both receptors of the two PTS-dependent import pathways. Cell 1997;89:83-92
30. Bjorkhem I, Sisfontes L, Bostrom B, et al. Simple diagnosis of the Zellweger syndrome by gas-liquid chromatography of dimethylacetals. J Lipid Res 1986;27:786-791
31. Mandel H, Espeel M, Roels F, et al. A new type of peroxisomal disorder with variable expression in liver and fibroblasts. J Pediatr 1994;125:549-555
32. Chang CC, Gould SJ. Phenotype-genotype relationships in complementation group 3 of the peroxisome-biogenesis disorders. Am J Hum Genet 1998;63:1294-1306
33. Sakai Y, Marshall PA, Saiganji A, et al. The Candida boidinii peroxisomal membrane protein Pmp30 has a role in peroxisomal proliferation and is functionally homologous to Pmp27 from Saccharomyces cerevisiae. J Bacteriol 1995;177:6773-6781
34. Erdman R, Blobel G. Giant peroxisomes in oleic acid-induced Saccharomyces cerevisiae lacking the peroxisomal membrane protein Pmp27p. J Cell Biol 1995;128:509-523
35. Schrader M, Reuben B, Morrell J, et al. Expression of PEX11 beta mediates peroxisome proliferation in the absence of extracellular stimuli. J Biol Chem 1998;273:29607-29614
36. Slawecki ML, Dodt G, Steinberg S, et al. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. J Cell Sci 1995;108:1817-1829
37. Braverman N, Steel G, Obie C, et al. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat Genet 1997;15:369-376
38. Dodt G, Braverman N, Wong C, et al. Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nat Genet 1995;9:115-125
39. Chang CC, Gould SJ. Phenotype-genotype relationships in complementation group 3 of the peroxisome-biogenesis disorders. Am J Hum Genet 1998;63:1294-1306
40. Dodt G, Gould SJ. Multiple PEX genes are required for proper subcellular distribution and stability of Pex5p, the PTS1 receptor: evidence that PTS1 protein import is mediated by a cycling receptor. J Cell Biol 1996;135:1763-1774
41. Portsteffen H, Beyer A, Becker E, et al. Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders. Nat Genet 1997;17:449-452
42. Reuber BE, Germain-Lee E, Collins CS, et al. Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders. Nat Genet 1997;17:445-448
43. Yahraus T, Braverman N, Dodt G, et al. The peroxisome biogenesis disorder group 4 gene, PXAAA1, encodes a cytoplasmic ATPase required for stability of the PTS1 receptor. EMBO J 1996;15:2914-2923
44. Gartner J, Obie C, Watkins P, Vale D. Restoration of peroxisome biogenesis in a peroxisome-deficient mammalian cell line by expression of either the 35 kDa or the 70 kDa peroxisomal membrane proteins. J Inherit Metab Dis 1994;17:327-329
45. Martinez M. Docosahexaenoic acid therapy in DHA-deficient patients with disorders of peroxisomal biogenesis. Lipids 1996; 31:S145-S152
46. Martinez M, Vazquez E. MRI evidence that docosahexanoic acid ethyl ester improves myelination in generalized peroxisomal disorders. Neurology 1998;51:26-32
47. Moser AB, Jones DS, Raymond GV, Moser HW. Plasma and red blood cell fatty acids in peroxisomal disorders. Neurochem Res 1999;24:187-197